Table 3.
OS (months) | PFS (months) | Response rate (%) | |
---|---|---|---|
Gemcitabine/CDDP/bevacizumab (7.5 mg/kg) HR (95% CI) | 13.6 | 6.7 | 34.1 |
0.92 (0.77–1.10) | 0.75 (0.62–0.91) | ||
Gemcitabine/CDDP/bevacizumab (15 mg/kg) HR (95% CI) | 13.4 | 6.5 | 30.4 |
1.02 (0.85–1.22) | 0.82 (0.68–0.98) | ||
Gemcitabine/CDDP | 13.1 | 6.1 | 20.1 |